A detailed history of American Century Companies Inc transactions in Novo Nordisk A S stock. As of the latest transaction made, American Century Companies Inc holds 1,467,963 shares of NVO stock, worth $128 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares
1,467,963
Previous 1,426,539 2.9%
Holding current value
$128 Million
Previous $204 Million 14.16%
% of portfolio
0.1%
Previous 0.13%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$119.07 - $145.42 $4.93 Million - $6.02 Million
41,424 Added 2.9%
1,467,963 $175 Million
Q2 2024

Aug 07, 2024

BUY
$122.71 - $146.91 $4.08 Million - $4.88 Million
33,226 Added 2.38%
1,426,539 $204 Million
Q1 2024

May 14, 2024

BUY
$102.11 - $135.92 $13 Million - $17.2 Million
126,855 Added 10.02%
1,393,313 $179 Million
Q4 2023

Feb 13, 2024

BUY
$87.78 - $105.45 $111 Million - $134 Million
1,266,458 New
1,266,458 $131 Million
Q3 2023

Nov 13, 2023

BUY
$90.94 - $199.54 $64.8 Million - $142 Million
712,745 Added 184.85%
1,098,332 $99.9 Million
Q2 2023

Aug 14, 2023

BUY
$155.98 - $172.65 $3.22 Million - $3.56 Million
20,624 Added 5.65%
385,587 $62.4 Million
Q1 2023

May 11, 2023

BUY
$132.34 - $159.14 $5.31 Million - $6.39 Million
40,139 Added 12.36%
364,963 $58.1 Million
Q4 2022

Feb 13, 2023

BUY
$102.55 - $135.33 $7 Million - $9.23 Million
68,239 Added 26.6%
324,824 $44 Million
Q3 2022

Nov 14, 2022

BUY
$95.28 - $116.93 $8.39 Million - $10.3 Million
88,021 Added 52.22%
256,585 $25.6 Million
Q2 2022

Aug 12, 2022

BUY
$103.24 - $121.81 $5.95 Million - $7.02 Million
57,623 Added 51.94%
168,564 $18.8 Million
Q1 2022

May 11, 2022

BUY
$93.1 - $112.54 $1.38 Million - $1.67 Million
14,816 Added 15.41%
110,941 $12.3 Million
Q4 2021

Feb 07, 2022

BUY
$95.88 - $117.08 $755,534 - $922,590
7,880 Added 8.93%
96,125 $10.8 Million
Q3 2021

Nov 10, 2021

BUY
$84.42 - $106.62 $997,675 - $1.26 Million
11,818 Added 15.46%
88,245 $8.47 Million
Q2 2021

Aug 05, 2021

BUY
$67.66 - $84.76 $788,712 - $988,047
11,657 Added 18.0%
76,427 $6.4 Million
Q1 2021

May 14, 2021

BUY
$67.06 - $75.82 $965,328 - $1.09 Million
14,395 Added 28.58%
64,770 $4.37 Million
Q4 2020

Feb 12, 2021

BUY
$63.89 - $73.8 $290,124 - $335,125
4,541 Added 9.91%
50,375 $3.52 Million
Q3 2020

Nov 13, 2020

BUY
$63.69 - $70.22 $565,567 - $623,553
8,880 Added 24.03%
45,834 $3.18 Million
Q2 2020

Aug 13, 2020

BUY
$58.54 - $67.94 $503,736 - $584,623
8,605 Added 30.35%
36,954 $2.42 Million
Q1 2020

May 14, 2020

BUY
$49.46 - $64.78 $922,330 - $1.21 Million
18,648 Added 192.23%
28,349 $1.71 Million
Q4 2019

Feb 12, 2020

BUY
$49.86 - $58.26 $483,691 - $565,180
9,701 New
9,701 $561,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $197B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track American Century Companies Inc Portfolio

Follow American Century Companies Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American Century Companies Inc, based on Form 13F filings with the SEC.

News

Stay updated on American Century Companies Inc with notifications on news.